NCT02642939 Study of Oral Mifepristone as Salvage Therapy in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT02633761 Mifepristone-misoprostol vs. Misoprostol Alone for Second Trimester Fetal Death Status TERMINATED Phase PHASE3
NCT02412618 Same-Day Mifepristone-Misoprostol Compared to Misoprostol Only for Surgical Abortion Cervical Preparation Status COMPLETED Phase PHASE4
NCT02354170 Short-Term Oral Mifepristone for Central Serous Chorioretinopathy Status COMPLETED Phase PHASE2
NCT02342002 Mifepristone and Misoprostol Versus Misoprostol Alone for Missed Abortion: A Randomized-controlled Trial Status TERMINATED Phase PHASE4
NCT02271958 Mifepristone 2.5, 5, 10 mg Versus Placebo in the Treatment of Endometriosis Status COMPLETED Phase PHASE2/PHASE3
NCT02046421 Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer Status COMPLETED Phase PHASE1
NCT02012491 Comparative Effectiveness of Pregnancy Failure Management Regimens Status COMPLETED Phase PHASE3
NCT02012296 Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01990560 Glucocorticoid Receptor Blockade With Mifepristone in Patients With Mild Adrenal Hypercortisolism Status COMPLETED Phase PHASE4
NCT01862991 Pre-Operative Effects of Mifepristone on Dilation and Evacuation Services Status COMPLETED Phase NA
NCT01856985 Acceptability of an Out-patient Regimen of Medical Abortion With Mifepristone and 800 Mcg Misoprostol Administered at 78-84 Days Gestation Status COMPLETED Phase PHASE4
NCT01811056 Exploring a Patient-centered Approach to Mifepristone Administration in Medical Abortion Status COMPLETED Phase NA
NCT01768299 Medical Abortion With Mifepristone + Misoprostol (13 - 22 Weeks) Status COMPLETED Phase PHASE4
NCT01636063 Mifepristone Versus Misoprostol for Cervical Preparation Prior to Surgical Abortion Between 11 to 15 Weeks Status TERMINATED Phase NA
NCT01631682 Pilot Study of Pharmaceutical and Behavioral Interventions to Treat Anxiety Disorders Status COMPLETED Phase PHASE4